Global Stroke Management Market Analysis 2024 – Estimated Market Size And Key Drivers|GE HealthCare Technologies Inc., Abbott Laboratories, Medtronic PLC, Boston Scientific Corporation, B Braun Melsungen AG, Bristol Myers Squibb Co.

The Stroke Management Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).

Learn More On The Stroke Management Market:
https://www.thebusinessresearchcompany.com/report/stroke-management-global-market-report

According to The Business Research Company’s Stroke Management Global Market Report 2024, The stroke management market size has grown strongly in recent years. It will grow from $36.94 billion in 2023 to $39.98 billion in 2024 at a compound annual growth rate (CAGR) of 8.2%. The growth in the historic period can be attributed to thrombolytic therapies, stroke prevention initiatives, rehabilitation techniques, telemedicine in stroke care, collaborative stroke networks.

The stroke management market size is expected to see strong growth in the next few years. It will grow to $52.89 billion in 2028 at a compound annual growth rate (CAGR) of 7.2%. The growth in the forecast period can be attributed to emergence of neuroprotective therapies, artificial intelligence in stroke diagnosis, personalized medicine approaches, expanding access to acute care, global stroke care standardization. Major trends in the forecast period include advancements in medical imaging technology, telemedicine and remote monitoring, focus on preventive care and risk factor management, neuroprotective therapies and drug innovations, collaboration and multidisciplinary approaches.

The increasing incidence of chronic diseases is expected to propel the growth of the stroke management market going forward. Chronic diseases refer to a problem that persists for a year or longer and impedes everyday activities, necessitates continuing medical care, or both. Stroke management assists patients suffering from various chronic diseases, such as cancer and cardiovascular diseases, by providing a timely focus on preventive, care, and support requirements through patient education and empowerment as well as the creation of care delivery models that integrate primary and secondary care. For instance, in January 2023, according to the National Library of Medicine a US-based biomedical library highlights, there will be 142.66 million people aged 50 and older in 2050 who have at least one chronic disease, up from 71.522 million in 2020, a 99.5% rise. Therefore, the increasing incidence of chronic diseases is driving the growth of the stroke management market going forward.

Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=9988&type=smp

The stroke management market covered in this report is segmented –

1) By Product Type: Diagnostics, Drug Therapy Products, Interventional Stroke Management Systems
2) By Application: Ischemic Stroke, Hemorrhagic Stroke
3) By End-User: Hospitals, Clinics, Ambulatory Surgery Centers, Diagnostic Centers, Retail Pharmacies, Online Pharmacies, Other End Users

Technological advancements are a key trend gaining popularity in the stroke management market. Companies operating in the stroke management market are adopting new technologies to sustain their position in the market. For instance, in November 2021, Qure.ai, an India-based artificial intelligence solution company, launched an AI stroke management platform to enable the remote diagnosis of emergency stroke cases. The AI imaging solution developed by the startup, called qER, powers the Qure.ai Stroke Management Platform. It is a triage and notification tool approved by the US FDA under 510(k) that can identify and quantify up to 12 abnormalities on head CT scans, including bleed, fracture, mass effect, and midline displacement. It aids in the early detection of stroke. Neurologists, radiologists, and neurosurgeons are among the stroke stakeholders who can examine clinical and imaging data using a companion mobile app for the stroke management system. It creates PDF reports and allows the viewing of DICOM files. Clinicians may share photos and reports, alter AI results, and more using the app.

The stroke management market report table of contents includes:

1. Executive Summary
2. Stroke Management Market Characteristics
3.Stroke Management  Market Trends And Strategies
4. Stroke Management  Market analysis
5.Stroke Management   Market Size And Growth
6. Stroke Management  Segmentation
7.Stroke Management  Regional And Country Analysis
.
.
.
27.Stroke Management  Competitive Landscape And Company Profiles
28.Stroke Management  Key Mergers And Acquisitions
29.Stroke Management  Future Outlook and Potential Analysis

TOP MAJOR PLAYERS:

• GE HealthCare Technologies Inc.
• Abbott Laboratories
• Medtronic PLC
• Boston Scientific Corporation
• B Braun Melsungen AG
• Bristol Myers Squibb Co

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293

Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model